Growth Equity

This lobby day will focus on the positive attributes of growth equity investing in the context of the unintentional damage that the Stop Wall Street Looting Act would have on any registered private firm, as well as a broader political campaign being waged against private equity. Should there be additional development at the SEC on our RIA work, participants will engage there as well.

***This event has been delayed due to health concerns surrounding COVID-19 (also called novel coronavirus). Please check back later for details about the rescheduled date.

Healthcare

This lobby day will be focused on healthcare policy, with an emphasis on drug pricing and the possible impact of pending legislation on new drug discovery and company formation. We may also discuss the importance of the Bayh-Dole Act, which is seminal legislation that paved the way for commercialization of federally funded research. The Bayh-Dole Act is 40 years old this year and has come under pressure in recent years. 

***This event has been delayed due to health concerns surrounding COVID-19 (also called novel coronavirus). Please check back later for details about the rescheduled date.